A positive take on negative selection for CAR-T manufacturing
Open Access
- 1 March 2024
- journal article
- editorial
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 32 (1) , 101218
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signatureBlood, 2024
- High-dimensional in situ proteomics imaging to assess γδ T cells in spatial biologyJournal of Leukocyte Biology, 2024
- Gamma/delta T cells as cellular vehicles for anti-tumor immunityFrontiers in Immunology, 2024
- Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and γδ T cell outputMolecular Therapy - Methods & Clinical Development, 2023
- A simple and effective method to purify and activate T cells for successful generation of chimeric antigen receptor T (CAR-T) cells from patients with high monocyte countJournal of Translational Medicine, 2022
- Dissecting the cellular components of ex vivo γδ T cell expansions to optimize selection of potent cell therapy donors for neuroblastoma immunotherapy trialsOncoImmunology, 2022
- CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell TrialJournal of Clinical Oncology, 2020
- Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cellNature Medicine, 2018
- Myeloid cells in peripheral blood mononuclear cell concentrates inhibit the expansion of chimeric antigen receptor T cellsCytotherapy, 2016
- Ex vivo isolation protocols differentially affect the phenotype of human CD4+ T cellsJournal of Immunological Methods, 2002